Related Experiment Video
Updated: Jul 3, 2025

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
Epigenome editing in cancer: Advances and challenges for potential therapeutic options
Seung-Won Lee1, Connor Mitchell Frankston2, Jungsun Kim3
1Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States; Department of Molecular and Medical Genetics, School of Medicine, Oregon Health & Science University, Portland, OR, United States.
Abstract:
Cancers are diseases caused by genetic and non-genetic environmental factors. Epigenetic alterations, some attributed to non-genetic factors, can lead to cancer development. Epigenetic changes can occur in tumor suppressors or oncogenes, or they may contribute to global cell state changes, making cells abnormal. Recent advances in gene editing technology show potential for cancer treatment. Herein, we will discuss our current knowledge of epigenetic alterations occurring in cancer and epigenetic editing technologies that can be applied to developing therapeutic options.
Insights
Epigenetic alterations, influenced by environmental factors, contribute to cancer development. Emerging epigenetic editing technologies offer promising new avenues for cancer therapy and treatment strategies.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Cancer arises from genetic and non-genetic factors, with epigenetic alterations playing a key role.
- Epigenetic changes can affect tumor suppressor genes and oncogenes, leading to abnormal cellular states.
- Environmental influences are increasingly recognized as contributors to epigenetic modifications in cancer.
Purpose of the Study:
- To review current understanding of epigenetic alterations in cancer.
- To explore the potential of epigenetic editing technologies for cancer treatment.
- To bridge the gap between epigenetic research and therapeutic applications.
Main Methods:
- Literature review of epigenetic alterations in various cancers.
- Analysis of current gene editing technologies applicable to epigenetics.
- Discussion of preclinical and clinical research in epigenetic therapy.
Main Results:
- Epigenetic modifications are hallmarks of cancer, impacting gene expression and cellular function.
- Gene editing tools, such as CRISPR-based epigenetic editors, are advancing rapidly.
- These technologies demonstrate potential for targeted reversal of cancer-associated epigenetic changes.
Conclusions:
- Epigenetic alterations are critical drivers of cancer development and progression.
- Epigenetic editing presents a novel therapeutic frontier for precision oncology.
- Further research is needed to translate these technologies into effective cancer treatments.
More Related Videos
Related Concept Videos
Epigenetic Regulation
X-chromosome...
CRISPR
Targeted Cancer Therapies
There are several types of targeted therapies against...
RNA Editing
What is Genetic Engineering?
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

